Regencell Bioscience Holdings Ltd
NASDAQ:RGC
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Regencell Bioscience Holdings Ltd
NASDAQ:RGC
|
HK |
|
Oriental Consultants Holdings Co Ltd
TSE:2498
|
JP |
|
S
|
Sky Tower PCL
SET:STOWER
|
TH |
|
Everest Metals Corporation Ltd
ASX:EMC
|
AU |
|
U
|
Unilever PLC
AEX:UNA
|
UK |
|
Asahi Net Inc
TSE:3834
|
JP |
|
B
|
Baxter International Inc
SWB:BTL
|
US |
Intrinsic Value
Is RGC undervalued or overvalued?
See the intrinsic value estimate for
Regencell Bioscience Holdings Ltd and find out whether today’s valuation is cheap or expensive by its own historical standards.
Do our valuations actually work? See backtest results .
Fundamental Analysis
What Regencell Bioscience Does
Regencell Bioscience Holdings is a small bioscience company focused on traditional Chinese medicine, especially formulas aimed at children with neurocognitive conditions such as autism and ADHD. Instead of making broad drug pipelines, it centers on a narrow set of TCM-based products and treatment approaches built around its own research and formulas.
- Headquarters
- Hong Kong HK
- Employees
- 10
- IPO date
- Jul 16, 2021
Earnings Waterfall
Regencell Bioscience Holdings Ltd
The intrinsic value for
Regencell Bioscience Holdings Ltd (RGC) under the Base Case is hidden USD.
Compared with the current market price of 7.27 USD, the stock appears hidden.